Lateral pelvic lymph node dissection in the management of locally advanced low rectal cancer

Zeneera Yusef, Brendan Zhen Yang Law, Yu En Ng, Emad H Aly* (Corresponding Author)

*Corresponding author for this work

Research output: Contribution to journalEditorial

3 Downloads (Pure)

Abstract

The management of rectal cancer has seen major developments over the last few decades (1) with increasing use of pre-operative imaging for local staging, more clear role for neoadjuvant chemoradiotherapy (nCRT) (2) and standardization of radical local resection with total mesorectal excision (TME) surgery which resulted in reduction of local recurrence rate to less than 10% (3). However, it has been increasingly recognized that patients with locally advanced low rectal cancer represent a particular challenge in terms of local disease control (4). This subgroup of patients is now known to have lateral pelvic lymph node (LPLN) metastasis in 15% to 20% which results in poor survival rates due to an increased risk of local and distant recurrence (5).

Original languageEnglish
Article number6
JournalDigestive Medicine Research
Volume3
Early online date25 Mar 2020
DOIs
Publication statusPublished - Mar 2020

Fingerprint Dive into the research topics of 'Lateral pelvic lymph node dissection in the management of locally advanced low rectal cancer'. Together they form a unique fingerprint.

  • Cite this